General Information of Drug (ID: DMQFS2D)

Drug Name
1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid
Synonyms CHEMBL515599; 1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid; SCHEMBL6686678
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 279.3
Logarithm of the Partition Coefficient (xlogp) 3.9
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C18H17NO2
IUPAC Name
1-benzyl-2,3-dimethylindole-7-carboxylic acid
Canonical SMILES
CC1=C(N(C2=C1C=CC=C2C(=O)O)CC3=CC=CC=C3)C
InChI
InChI=1S/C18H17NO2/c1-12-13(2)19(11-14-7-4-3-5-8-14)17-15(12)9-6-10-16(17)18(20)21/h3-10H,11H2,1-2H3,(H,20,21)
InChIKey
NSKDMNCONIAVGH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44564825
ChEBI ID
CHEMBL515599
TTD ID
D0YW9C
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8.